| Sep 18 |
Femasys Announces Infertility Clinic Customers from Coast to Coast
|
| Sep 12 |
Femasys Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
|
| Sep 11 |
Femasys secures partnerships for commercialization of Femaseed and FemVue
|
| Sep 11 |
Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market
|
| Sep 10 |
Femasys Stock Rises After FDA Clearance for FemChec Diagnostic Device
|
| Sep 9 |
FDA clears FemChec for fallopian tube occlusion testing
|
| Sep 9 |
Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check
|
| Sep 9 |
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
|
| Sep 5 |
Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting
|
| Sep 3 |
Femasys Shares Rise on CE Mark & Canada Approval for FemVue MINI
|
